Hospitalist · Scranton, PA
NPI
1679854178
Since 2011
Specialty
Hospitalist
Code 208M00000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1800 Mulberry St
Scranton, PA, 18510
Phone (570) 703-7351
Groups this clinician bills Medicare through
Medicare paid, 2024
$46K
802 services
Medicare patients, 2024
132
Average age 72
Drug cost, 2024
$1.9M
791 prescriptions
Company payments, 2025
$168
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mina M Makary was code 99215 (office e&m - established), 242 times for 80 patients. In total Mina M Makary billed 802 services in 11 codes, and Medicare paid $46K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-04-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 242 | 80 | $100.02 | $24K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 201 | 75 | $11.91 | $2,395 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 101 | 34 | $23.60 | $2,384 |
| 99215 Office E&M - Established | Office | 66 | 27 | $104.78 | $6,916 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 52 | 26 | $12.23 | $636 |
| G0316 Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by th | Facility | 48 | 21 | $22.86 | $1,097 |
| 99233 Hospital E&M - Subsequent | Facility | 20 | 16 | $85.84 | $1,717 |
| 99205 Office E&M - New | Facility | 20 | 20 | $131.18 | $2,624 |
| 99223 Hospital E&M - Initial | Facility | 12 | 12 | $130.83 | $1,570 |
By year: 2022 $3,014 for 26 services; 2023 $33K for 371 services; 2024 $46K for 802 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mina M Makary prescribed most often to Medicare patients was Prednisone, with 72 prescriptions and refills. In total Mina M Makary wrote 791 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 72 | 74 | 14 | $260 |
| Anastrozole Generic | 70 | 202 | 24 | $2,338 |
| Abiraterone Acetate Generic | 67 | 69 | 11 | $98K |
| Olanzapine Generic | 55 | 65 | 27 | $485 |
| Prochlorperazine Maleate Generic | 47 | 47 | 27 | $645 |
| Dexamethasone Generic | 45 | 45 | 19 | $439 |
| Xtandi Enzalutamide | 45 | 45 | Under 11 | $650K |
| Allopurinol Generic | 37 | 53 | Under 11 | $293 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 34 | 36 | 29 | $451 |
| Potassium Chloride Generic | 30 | 38 | 15 | $486 |
| Acyclovir Generic | 27 | 37 | Under 11 | $326 |
| Ondansetron Hcl Generic | 24 | 24 | 14 | $190 |
| Eliquis Apixaban | 20 | 27 | Under 11 | $14K |
| Tamoxifen Citrate Generic | 17 | 45 | Under 11 | $527 |
| Duloxetine Hcl Generic | 15 | 31 | Under 11 | $517 |
Brand drugs: - claims; generic drugs: 652 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mina M Makary $168 ($168 in general payments such as food, travel and fees) from 2 companies. The largest payer was Syndax Pharmaceuticals, Inc. with $125.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.